HPV Type-Specific Prevalence a Decade after the Implementation of the Vaccination Program: Results from a Pilot Study
Human papillomavirus infection is a cause of the development of invasive cervical cancer. Three types of vaccine are currently available to prevent precancerous/cancerous lesions due to persistent infection, which is supported mainly by 7 different high-risk genotypes. The aim of this pilot study wa...
Main Authors: | Clara Fappani, Silvia Bianchi, Donatella Panatto, Fabio Petrelli, Daniela Colzani, Stefania Scuri, Maria Gori, Antonella Amendola, Iolanda Grappasonni, Elisabetta Tanzi, Daniela Amicizia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/4/336 |
Similar Items
-
Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay
by: Pornjarim Nilyanimit, et al.
Published: (2017-10-01) -
Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS
by: Giovanna Orlando, et al.
Published: (2019-08-01) -
Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
by: Brandon Wen Bing Chua, et al.
Published: (2022-05-01) -
Urine HPV in the Context of Genital and Cervical Cancer Screening—An Update of Current Literature
by: Alexandros Daponte, et al.
Published: (2021-04-01) -
Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine
by: Jade Pattyn, et al.
Published: (2020-08-01)